This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Aug;50(4):456-457.

doi: 10.1111/apt.15319.

Editorial: when cirrhosis deserves haemodialysis-rethinking strategies

Enric Reverter¹

Affiliations

PMID: 31359478
DOI: 10.1111/apt.15319

Editorial

Editorial: when cirrhosis deserves haemodialysis-rethinking strategies

Enric Reverter. Aliment Pharmacol Ther. 2019 Aug.

. 2019 Aug;50(4):456-457.

doi: 10.1111/apt.15319.

Author

Enric Reverter¹

Affiliation

¹ Liver and Digestive ICU, Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

PMID: 31359478
DOI: 10.1111/apt.15319

No abstract available

PubMed Disclaimer

Comment in

Editorial: when cirrhosis deserves haemodialysis-rethinking strategies. Authors' reply.
Artru F, Louvet A, Hazzan M, Mathurin P. Artru F, et al. Aliment Pharmacol Ther. 2019 Aug;50(4):457-458. doi: 10.1111/apt.15366. Aliment Pharmacol Ther. 2019. PMID: 31359475 No abstract available.

Comment on

The prognostic impact of cirrhosis on patients receiving maintenance haemodialysis.
Artru F, Louvet A, Glowacki F, Bellati S, Frimat M, Gomis S, Castel H, Barthelon J, Lassailly G, Dharancy S, Noel C, Hazzan M, Mathurin P. Artru F, et al. Aliment Pharmacol Ther. 2019 Jul;50(1):75-83. doi: 10.1111/apt.15279. Epub 2019 May 14. Aliment Pharmacol Ther. 2019. PMID: 31087566

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information